Amarin Corporation PLC/UK - Ordinary Shares, par value 50 pence per share (AMRN)

CUSIP: 023111206

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
-1,557,210
Put/Call ratio
20%
SEC-reported price per share
$0.45
Number of holders
127
Value change
-$786,926
Number of buys
35
Open additional details 1 more signal available
Number of sells
72
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
422,724,138

Security key

023111206

Report period

Q1 2025

Institutions

127

Top holders

10

Ownership snapshot

Top reported holders of AMRN - Amarin Corporation PLC/UK - Ordinary Shares, par value 50 pence per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Sarissa Capital Managemen...
Disclosed value leader
Sarissa Capital Managemen...
Comparable rows
0/15
Latest evidence
31 Dec 2024
13F 3/4/5 Highest disclosed value: $12,052,552 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Sarissa Capital Management LP has the largest disclosed position value at $12.05M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Sarissa Capital Management LP's linked filing trail.
Disclosed position value Top 5
Sarissa Capital Management LP $12.05M
Kynam Capital Management, LP $6.02M
John F. Thero $3.55M
MORGAN STANLEY $2.14M
SCP Investment, LP $1.21M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Sarissa Capital Management LP
13F
Company
13F
—
denominator unverified
$12,052,552
24,850,623 shares
— 31 Dec 2024
Kynam Capital Management, LP
13F
Company
13F
—
denominator unverified
$6,021,095
12,414,628 shares
— 31 Dec 2024
John F. Thero
3/4/5
President and CEO, Director
—
mixed-class rows
$3,545,500
3,266,224 shares
mixed-class rows
— 30 Jul 2021
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$2,137,115
4,406,422 shares
— 31 Dec 2024
SCP Investment, LP
13F
Company
13F
—
denominator unverified
$1,212,500
2,500,000 shares
— 31 Dec 2024
Waterfront Wealth Inc.
13F
Company
13F
—
denominator unverified
$1,203,655
2,481,766 shares
— 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
127
Shares
67,596,304
Rows available
127
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2026 Across Filers

Q1 2026 holders
2
Q1 2025 holders
127
Holder diff
125
Investor Q1 2026 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2026 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .